DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Reset all filters
01 1DR. REDDY'S LABORATORIES LIMITED Hyderabad IN
02 2UNIMARK REMEDIES LIMITED Mumbai IN
03 1APITORIA PHARMA PRIVATE LIMITED Hyderabad IN
04 1FORMOSA LABORATORIES, INC. Taoyuan TW
05 1HETERO DRUGS LIMITED Hyderabad IN
06 1LAURUS LABS LIMITED Hyderabad IN
07 1LAURUS LABS PRIVATE LIMITED Hyderabad IN
08 2MACLEODS PHARMACEUTICALS LIMITED Mumbai IN
09 2MELODY HEALTHCARE PVT. LTD. Boisar IN
10 1MOREPEN LABORATORIES LIMITED Baddi IN
11 1MSN PHARMACHEM PRIVATE LIMITED Pashamylaram Village IN
12 1MSN PHARMACHEM PRIVATE LIMITED Sangareddy District IN
13 1SHANDONG NEW TIME PHARMACEUTICAL CO., LTD. Linyi CN
14 2TAPI NL B.V. Amsterdam NL
15 2TIANISH LABORATORIES PRIVATE LIMITED Hyderabad IN
16 1ZHEJIANG TIANYU PHARMACEUTICAL CO., LTD. Taizhou City CN
Reset all filters
01 12Montelukast sodium
02 1Montelukast sodium, 1556
03 1Montelukast sodium, Alternate process
04 1Montelukast sodium, Amorphous, non-micronised and micronised
05 1Montelukast sodium, ID 6177
06 1Montelukast sodium, MK
07 1Montelukast sodium, Milled and micronised
08 1Montelukast sodium, Process B
09 1Montelukast sodium, Process II
10 1Montelukast sodium, Process-II
Reset all filters
01 2China
02 16India
03 1Taiwan
04 2Blank
Reset all filters
01 2Expired
02 1Suspended by Holder
03 16Valid
04 2Withdrawn by Holder
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Certificate Number : R1-CEP 2012-115 - Rev 03
Status : Valid
Issue Date : 2023-07-12
Type : Chemical
Substance Number : 2583
Certificate Number : R1-CEP 2012-288 - Rev 00
Status : Suspended by Holder
Issue Date : 2021-07-07
Type : Chemical
Substance Number : 2583
Certificate Number : R0-CEP 2012-331 - Rev 00
Status : Expired
Issue Date : 2015-01-23
Type : Chemical
Substance Number : 2583
Certificate Number : R1-CEP 2013-278 - Rev 00
Status : Valid
Issue Date : 2021-07-23
Type : Chemical
Substance Number : 2583
Montelukast Sodium, Alternate Process
Certificate Number : CEP 2013-311 - Rev 02
Status : Valid
Issue Date : 2024-11-25
Type : Chemical
Substance Number : 2583
Certificate Number : R0-CEP 2019-211 - Rev 00
Status : Valid
Issue Date : 2022-06-03
Type : Chemical
Substance Number : 2583
Certificate Number : CEP 2024-390 - Rev 00
Status : Valid
Issue Date : 2025-02-26
Type : Chemical
Substance Number : 2583
Certificate Number : R1-CEP 2015-135 - Rev 00
Status : Valid
Issue Date : 2022-05-30
Type : Chemical
Substance Number : 2583
Montelukast Sodium, Amorphous, Non-micronised An...
Certificate Number : CEP 2012-091 - Rev 01
Status : Valid
Issue Date : 2025-02-17
Type : Chemical
Substance Number : 2583
Certificate Number : R1-CEP 2014-115 - Rev 01
Status : Valid
Issue Date : 2021-07-16
Type : Chemical
Substance Number : 2583
88
PharmaCompass offers a list of Montelukast Sodium API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Montelukast Sodium manufacturer or Montelukast Sodium supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Montelukast Sodium manufacturer or Montelukast Sodium supplier.
PharmaCompass also assists you with knowing the Montelukast Sodium API Price utilized in the formulation of products. Montelukast Sodium API Price is not always fixed or binding as the Montelukast Sodium Price is obtained through a variety of data sources. The Montelukast Sodium Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Kipres manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Kipres, including repackagers and relabelers. The FDA regulates Kipres manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Kipres API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Kipres manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Kipres supplier is an individual or a company that provides Kipres active pharmaceutical ingredient (API) or Kipres finished formulations upon request. The Kipres suppliers may include Kipres API manufacturers, exporters, distributors and traders.
click here to find a list of Kipres suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Kipres CEP of the European Pharmacopoeia monograph is often referred to as a Kipres Certificate of Suitability (COS). The purpose of a Kipres CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Kipres EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Kipres to their clients by showing that a Kipres CEP has been issued for it. The manufacturer submits a Kipres CEP (COS) as part of the market authorization procedure, and it takes on the role of a Kipres CEP holder for the record. Additionally, the data presented in the Kipres CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Kipres DMF.
A Kipres CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Kipres CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Kipres suppliers with CEP (COS) on PharmaCompass.
We have 13 companies offering Kipres
Get in contact with the supplier of your choice: